User:Annamirly/Medical–industrial complex

The medical–industrial complex (MIC) refers to a network of interactions between pharmaceutical corporations, health care personnel, and medical conglomerates to supply health care-related products and services for a profit. The term is derived from the idea of the military–industrial complex.

Following the MIC's conception in 1970, the term has undergone an evolution by critical theory scholars throughout the early 21st century – including but not limited to the fields of disability studies, Black studies, feminism, and queer studies – to describe forces of oppression against marginalized communities as they exist in the healthcare field. Mia Mingus, a writer, educator, and disability justice advocate, is one of such notable scholars who created a visual of the MIC. Prior to the conception of the "medical-industrial complex" term, themes related to the MIC were discussed in earlier American society, as shown through the work and philosophies of Rana A. Hogarth and Francis Galton.

The medical–industrial complex is often discussed in the context of conflict of interest in the health care industry and is often regarded as a result of modernized healthcare and capitalism. Discussions regarding the medical-industrial complex often include the United States healthcare system. These discussions about the MIC propose that pharmaceutical and healthcare companies, including for-profit chain hospitals, may influence physicians through financial incentives. Physicians may also face constraints from corporate regulations and potential conflicts of interest related to investments in medical device companies. Although some large medical journals have been criticized for potentially biased publications, efforts have been made to maintain neutrality in medical literature. Continuing medical education programs funded by pharmaceutical companies may also influence physician preferences. Finally, patients may be affected by the MIC through the promotion of cosmetic surgery, drug price inflation, and physician bias. The Food and Drug Administration has implemented laws to protect patients against the potential negative impacts of the medical-industrial complex in the United States. These perspectives on the medical-industrial complex also apply to countries outside the United States, such as India and Brazil.

Drawing from diverse theoretical frameworks and the collective efforts of historically marginalized communities, critics have proposed alternatives to the medical-industrial complex that aim to reimagine health as a holistic concept, challenge the medicalization of sickness, and integrate lived experiences into healthcare settings.

Origin
In 1961, President Dwight D. Eisenhower commented on the influence and immensity of the military in American society in his farewell address, “...we must guard against the acquisition of unwarranted influence, whether sought or unsought, by the military-industrial complex.” This new term, the military-industrial complex, depicts a sphere of influence between a national military and the defense industry which provides essential supplies to the military. Deriving from this, the compound term composed of the intended institution with “industrial complex” is created to describe the conflict of interest between an institution's supposed goal, and the desire to profit from the businesses/agencies that profit from serving the institution. The conceptual framework of the medical-industrial complex sits alongside the military-industrial complex and the prison-industrial complex, among others, to delineate the influence of free market capitalism in sociopolitical systems/institutions.

The concept of a "medical–industrial complex" was first advanced by Barbara and John Ehrenreich in the November 1969 issue of the Bulletin of the Health Policy Advisory Center in an article entitled "The Medical Industrial Complex" and in a subsequent book (with Health-PAC), The American Health Empire: Power, Profits, and Politics (Random House, 1970). In “The Medical Industrial Complex,” the emergence of the American medical industrial complex is attributed to “the growing rapport between the delivery and products industry.” This definition of the medical-industrial complex describes the history of the American healthcare system, specifically the creation of social programs Medicare and Medicaid, as an industry that has transformed into a central, essential role of the American national economy. References to the perpetuation of healthcare disparities by the medical-industrial complex are described, such as “class and cultural antagonisms.” Differences in accessibility of healthcare between rural and urban populations are also made at this time.

In 1980, Dr. Arnold S. Relman published a further discussion of the medical-industrial complex in The New England Journal of Medicine when he was editor-in-chief, entitled “The New Medical-Industrial Complex.” Relman notably explicitly excludes pharmaceutical companies and medical equipment companies in his description of the medical-industrial complex. Relman argues that “in a capitalistic society there are no practical alternatives to the private manufacture of drugs and medical equipment.” Relman still identifies the novelty of the modern medical-industrial complex, describing the medical-industrial complex as an “unprecedented phenomenon with broad and potentially troubling implications.” As with the Ehrenreich definition, the medical-industrial complex continues an emphasis on profit maximization on behalf of private corporations. The “cream-skimming” phenomenon is described, where proprietary hospitals can “skim the cream” off the market, by focusing on wealthy patients who can afford the most profitable procedures and services; nonprofit hospitals are therefore left with the remaining patient base.

In the 21st century, the medical industrial complex has come to encompass a system of oppression and subject of critical analysis by scholars, activists, organizers, and advocates. The Health Justice Commons describes the medical-industrial complex as intertwined institutions, including big pharma, as well as health insurance companies, medical technology companies, and governmental regulatory bodies. Per the Health Justice Commons, the medical-industrial complex reinforces “racism, sexism, classism, homophobia, transphobia and ableism." The nature and extent of the medical-industrial complex is a subject of debate by scholars, including those who specialize in fields of critical theory, such as disability studies, queer theory, and Black studies. One such contributor is Mia Mingus, a writer and educator, who has attempted to visualize the medical industrial complex graphically.

Her map of the medical industrial complex can be found here.

Image Description of Map: “There are four main quadrants, each in a different color with large matching colored arrows connecting the outer broad categories to inner underlying motives: “Science and Medicine” is connected to “Eugenics;” “Access” to “Charity and Ableism;” “Health” to “Desirability;” and “Safety” to “Population Control.”

Mia Mingus' diagram of the medical industrial complex diagram in her blog entitled Leaving Evidence suggests that: (1) at the root of our societal conception of health is desirability, (2) at the root of safety is population control, (3) at the root of access is charity and ableism, and (4) at the root of science and medicine is eugenics. Mingus shows the connection between health and desirability by providing examples of forced healing and cosmetic medical procedures that alter individuals within the health industry. She connects safety to population control by highlighting the prison industrial complex. Mingus roots access in charity and ableism by describing institutions such as non-profits and insurance companies. She states that “non-profits were included directly next to Charity and Eugenics because of the ways that they have helped to frame how we understand things such as “cure” and “rescue,” and dutifully fundraised millions of dollars in the process." Similarly, according to encyclopedia.com, the Medical-Industrial Complex has “certainly contributed to improvements in the health status of the population,” but “it has also strengthened and preserved the private sector and protected a plurality of vested interests.” Finally, Mingus’ diagram roots science and medicine in eugenic practices, providing bio-colonialism as evidence for this connection.

History
The existence of the medical-industrial complex as a concept is a product of the development of the modern American healthcare system. In the 19th century, the profession and practice of medicine underwent significant professionalization and growth. Experimentation on enslaved people was common. Doctors such as gynecologist J. Marion Sims operated on enslaved black women without anesthesia in order to document and develop gynecological medical issues and techniques to repair them. The creation of hospitals to treat the sick create further disparities in favor of urban, white populations.

The contemporary American healthcare system was shaped by the passage of the Hill-Burton Act, Medicare, Medicaid, and most recently, the Affordable Care Act. The latter social programs attempt to diminish the disparity of populations with difficulties maintaining health insurance, but does not attempt to reduce the private sector. The medical-industrial complex endeavors to reconcile the modern healthcare establishment with the long term health inequalities.

Some elements of the medical-industrial complex, including the experimentation on marginalized populations, were introduced much prior to the modern American healthcare system. The conglomerate as it is now known is the synthesis of the modern healthcare system with developed capitalism.

1780 - 1840
In the historical monograph Medicalizing Blackness: Making Racial Differences in the Atlantic World, 1780-1840, Rana A. Hogarth discusses the “the ways in which blackness was reified in medical discourses and used to perpetuate notions of white supremacy,” and, consequently, harm and oppression. For example, Hogarth discusses how “white physicians constructed images of healthy and robust black bodies capable of enduring brutal labor regimes” while also identifying “deficiencies within these bodies that disqualified them for self-government.” Importantly, Hogarth argues that oppression of black individuals using science predates the justification of slavery, and, instead has more to do with the origins of the medical industrial complex that allowed for the “intellectual, professional, and pecuniary gains” of physicians in the English-speaking greater Caribbean region over those of black individuals.

1900s - Present Day
Eugenics has played a prominent role in the history of the MIC. The term eugenics was introduced in 1904, by Francis Galton. It was defined as “the science which deals with all influences that improve and develop the inborn qualities of a race” with the goal of “represent[ing] each class or sect by its best specimens, causing them to contribute more than their proportion to the next generation.” Galton’s concept of eugenics soon propagated ideas that certain groups of people, whether they were distinguished by race, ability, or socioeconomic status, were superior to others. Renowned journals, such as Nature, published work by Galton and other eugenicists, thereby making it easier for eugenics to become a legitimate field in science.

Some instances of eugenics are infamous in society, such as the justification of the mass ethnic genocide of Jewish people during the Holocaust by arguing that society was in need of racial purification.

Other examples of eugenics, such as the selective abortion of children with disabilities, are more controversial. Other notable eugenic-like practices include compulsory sterilization of black and poor individuals and scientific racism.

For more, see eugenics.

Healthcare Corporations
Pharmaceutical companies and chain hospitals are key healthcare corporations within the Medical Industrial complex.

Influence of Pharmaceutical Companies
Pharmaceutical companies are a leading influence in the expansion of the Medical-Industrial Complex. Generic pharmaceutical drugs, which have the same chemical properties as branded, profitable drugs, are often sold for a fraction of the cost of their counterparts. For example, a 10 mg dose of asthma medication Singulair can cost up to $250 per month, whereas its generic counterpart Montelukast costs only ~$20 per month. Despite the inflated prices of brand-name drugs, pharmaceutical companies often induce bias in health care professionals by disproportionately promoting brand-name drugs. For example, research has shown that pharmaceutical companies promote branded drugs more, making physicians more likely to prescribe an expensive medicine over a generic alternative.

In addition to drugs, Laboratory Tests are also influenced by pharmaceutical company's vested interests. Physicians are more likely to order unnecessary tests when they are advertised by familiar pharmaceutical companies. Like branded drugs, many pharmaceutical companies set these tests at inflated prices to increase profit.

Influence of Chain Hospitals
Chain hospitals, in collaboration with pharmaceutical companies, also lead to the escalation of health costs. A chain hospital is a subsidiary of a hospital network that works under a for-profit goal of expanding healthcare and establishing hospitals across a country, most notably the United States. These corporations set standards regarding care administration, regulation, and enforcement – often without implementing a proper code of medical ethics. Chain hospitals and other healthcare conglomerates hold a monopoly over health care costs within their hospitals and respective subsidiaries. Thus, they can inflate healthcare costs with the goal of increasing profit, or lowering hospital standards to cut corners where necessary.

This cost inflation is exacerbated by the fact that health care organizations are increasingly managed by business staff who often focus on economic gain, rather than local medical practitioners whose focus is patient benefit. Moreover, hospitals in one state can be monitored by systems elsewhere, which gives significantly less power to local healthcare professionals.

Bias in Medical Education
The curriculum of medical students often incorporates readings from large medical journal s, like the New England Journal of Medicine. These peer-reviewed journals may present results that favor expensive drugs manufactured by healthcare corporations or pharmaceutical companies, as these same corporations help to fund the journal. As such, these large journals can perpetuate bias in healthcare providers' medication preferences by presenting results that are inherently influenced by the motives of businesses.

Continuing Medical Education
Beyond medical school education, continuing medical education for healthcare is also subject to biased curriculum that disproportionately promotes the interest of its funders. To continue practicing as a board-certified physician, a physician must take continuing medical education courses. Such programs ensure that physicians are up-to-date with new medicines and treatment plans. However, these continuing education courses are often sponsored by pharmaceutical companies and healthcare corporations that can instill bias in physicians' education via the material provided. For example, if a course is sponsored by a medical device company, then the coursework and exams used often reference using the company's medical device. In turn, when the course is completed, it is more likely that physicians will use that medical device when interacting with patients regardless of if that medical device is necessary in the patients treatment.

There are entities that work to reduce bias in continuing medical education courses, including the Accreditation Council for Continuing Medical Education. Other groups, like the Medical education agency, work to reduce the influence of pharmaceutical companies and hospital corporations in the continuing medical education process.

Consequences
The MIC poses unique difficulties for patients and physicians. For patients dealing with recent wide-spread diseases, like COVID-19, treatment often comes with steep prices in Medicare and insurance. In recent 2020 health-care research, data has expressed how pandemics like COVID-19 have further tested the preparedness of the entire system's ability to combat a rapidly spreading virus.

Patient-level
A health professional offers a unique service to patients, since patients often defer to the guidance and wisdom of their healthcare provider. Many healthcare corporations are cognizant of the general population's lack of medical knowledge and possess the ability to set prices. This unequal relationship between healthcare corporations and the populous is especially important as it involves the complex interaction between making a profit from a patient's suffering, but also physicians having to treat the patient as effectively as possible. For patients who do not have access to reliable health insurance, this system imposes expensive medical treatment that they must pay for.

For patients with a chronic illness, diagnosis often means expensive medications for the rest of one's life. Chronic illnesses like depression may require medications until the disease is treated, whereas more severe chronic illnesses like cystic fibrosis require expensive medical and pharmaceutical treatments for one's entire life. These diseases could be treated, but their unique long-lasting nature means money can be generated from life-long treatments as opposed to a curative treatment.

Individuals in low-income households and racial minority groups have experienced most of the impact of the high prices in the medical-industrial complex during the pandemic. Over one third of Latino adults or low-income adults were uninsured at some point during 2020. In 2020, African Americans infected with COVID-19 died at a rate of 97.9 out of every 100,000, which is a death rate over twice as high as the death rates in white people (46.6/100,000) and Asians (40.4/100,000), and a third higher than Latinos (64.7/100,000). Notably, the death rate of African Americans is comparable to that of Indigenous populations (81.9/100,000).

Physician-level
Physicians are also subject to the medical-industrial complex and its manifestations. Throughout the 21st century, plastic surgery has become more common, a process where individuals undergo surgeries to resolve cosmetic issues. Cosmetic surgeries are often used to satisfy a certain beauty standard. An example of this is a rhinoplasty, which is a nose surgery that is oftentimes a purely cosmetic surgery, and therefore not life-saving. For-profit healthcare promotes such non-essential healthcare services so that more profits can be created from healthy populations.

The phrase "no margin, no mission" is often used to describe for-profit healthcare, where medical centers adapt to corporate interests. For physicians, this can mean not treating uninsured patients, performing unnecessary procedures that generate profit, or supplying better care to patients when they have better means of pay. For-profit healthcare can have great moral and ethical considerations for physicians who feel obligated to care more for well-insured patients as opposed to under-insured, vulnerable patients.

Corporate entities, including insurance companies, also enforce standards surrounding medical treatment and payout. These rules disregard ethical and moral dilemmas that physicians often face, setting unattainable guidelines for certain situations. Physicians are often tied between healthcare corporations and insurance companies determining what they can and cannot do for a patient, regardless of if the treatment plan is necessary or not.

Manufacturers of medical devices also fund medical education programs, physicians, and hospitals to encourage the use of their devices. Many pharmaceutical and medical device companies are investor-based, meaning that if a device or drug receives FDA approval, investing physicians will be financially invested in the device's success or demise. Thus, a physician who is financially involved in a product or service is more likely to promote or use the product, whether or not its efficacy is known. This provides a conflict of interest for physicians, who may not provide their patients with effective, safe treatment due to bias for one product over another.

Laws and Policies
As indicated in Mia Mingus' diagram above, the "Medical Industrial Complex" is intertwined with the effects of economic policy on the practice of medicine. The Dalkon Shield is an interesting example of the conflict between economic profit and patient well being:

The Dalkon Shield was an IUD introduced in the late 1970's and 1980's. The manufacturers of the device claimed that their IUD was safer than other forms of birth control available, and none of their reports noted any safety issues. However, the long-term effects of the Dalkon Shield were not well known, and the IUD ended up being both ineffective and dangerous, resulting in many women becoming pregnant and facing severe pregnancy complications. Moreover, because the device promised pregnancy prevention, many fetuses with severe birth defects were born as mothers did not follow medically-advised precautions during their pregnancy. When the device was discontinued after CDC and FDA investigations, the IUDs was still not recalled and continued to endanger women who had them. As such, the Dalkon Shield remained a dangerous medical device available in the healthcare market.

Over a decade since the invention of the Dalkon Shield, the Safe Medical Devices Act of 1990 was passed by the FDA as an amendment to the FDCA. This act required medical device manufacturer to report any information about medical devices that could contribute to death, sickness, or injury. As such, healthcare professionals were required to report malfunctioning or unsafe medical equipment.

Additionally, the Physician Payments Sunshine Act, created by the United States Department of Justice, declared that all contracts that medical device companies make with physicians must be made public. As such, this act could prevent future physicians from promoting or overusing medical devices on patients to further personal interests over patient benefit.

In other countries
The healthcare system in the United States performs worse on health indicators compared to other major nations, despite the country's higher investment in healthcare. This is reflected in lower ratings for life expectancy and satisfaction among U.S. citizens. Some argue that these lower ratings are partly due to the fact that the United States does not provide universal health coverage, unlike many other nations. Some major differences between the United States and other major countries include quality, access, efficiency, equity, and life expectancy.

White Savior Industrial Complex (WSIC)
See also: White savior

Countries in the Global South do not always have the same amount and quality of resources as countries in the Global North. Due to these disparities, scholars argue that the White Savior Industrial Complex (WSIC) has influenced healthcare systems on individual, interpersonal, structural, and global levels. Coined by Teju Cole, the WSIC refers to the phenomenon where privileged white individuals seek personal fulfillment by trying to "liberate, rescue, or otherwise uplift underprivileged people of color." According to this concept, people with a white savior mentality may believe they know what is best for other countries, although such individuals often end up causing more harm than good. One such example describes how a white American physician caused Ugandan medical staff to doubt their knowledge and ability in delivering a baby. Another example recounts how a White male physician used his privilege to influence medical staff in India to subvert their traditional medical practices. Scholars cite these anecdotes as examples of how widespread the WSIC has become.

India
Some individuals claim that the medical-industrial complex also exists in India, where the Indian Medical Association lobbies for their interests in local and state politics. Specifically, some doctors have accused the Indian Medical Association of engaging in unethical practices and obstructing the advancement of healthcare systems within the medical profession. The Indian Medical Association has responded to these claims by stating that their critics exaggerate rare occasions of unethical practices. Yet, some doctors have privately admitted to immoral actions and have stated that these practices are not limited to a few individual patients. Ethics is a contentious topic both within and beyond the medical profession. Claims of unethical practices may stem from the stark contrast between healthcare systems ranging from tall, high-tech hospitals to dilapidated, dirty ones. Some medical professionals and scholars suggest that stricter office guidelines may decrease unethical practices, but this could also raise the cost of healthcare for patients.

Brazil
In Brazil, scholars refer to the medical-industrial complex as the "healthcare-industrial complex." The healthcare-industrial complex also expands beyond Brazil, where internal infrastructure fails to meet medical demands, leaving patients unable to access necessary products and services. Scholars argue that Brazil's medical history reflects poor distribution of social and economic medical policies, resulting in underdeveloped and underfunded healthcare sectors in poor communities. The Program for Investment in the Health Industrial Complex, or PROCIS, funds medical research in Brazil to advance the country's global presence in pharmaceutical and medical industries. According to the Brazilian Ministry of Health, PROCIS was formed with the goal of developing Brazil's internal healthcare structure and promoting research, development, and treatment. Over 100 billion Brazilian reals have been devoted to supporting medical research efforts, development of the medical industry, and innovating existing medical products. The PROCIS also established a margin of preference on healthcare products that are nationally funded and sourced.

Cultural Criticisms
A group of scholars and activists offer critiques and alternative approaches to the medical-industrial complex.

Alternative approaches
Alternative approaches to the medical-industrial complex incorporate elements from different theoretical frameworks and practices, such as holism, environmentalism, reproductive justice, the disability rights movement, feminism, and other related concepts. These alternative approaches stem from the collective efforts of historically marginalized activists facing structural violence, including Indigenous, Black, and migrant communities. According to various scholars, these alternative approaches aim to reimagine health as a holistic concept that extends beyond the traditional focus of the medical-industrial complex to include the body, mind, and spirit. Furthermore, these alternative approaches challenge the medicalization of illness and disease by highlighting how structural factors shape health, rather than just individual behaviors. Alternative approaches to the medical-industrial complex also challenge the boundaries between patient and provider to encourage collaboration between the two and to center the lived experiences of individuals in the healing process. Additionally, they highlight the importance of forming caring relationships within one’s community to establish a sense of solidarity among individuals as equal participants in the healing process.

One alternative approach to the MIC is presented by disability activist, Eli Clare, who describes the Medical-Industrial Complex in a negative light, stating that, through the MIC “all of our body-­minds are judged in one way or another, found to be normal or abnormal, valuable or disposable, healthy or unhealthy.” He argues that the MIC is a critical component of the ideology of cure by shaping “our understandings of health and well-­ being, disability and disease” and perpetuating the idea that bodies and minds need improving. Clare describes the MIC as being pervasive throughout our lived experiences, “sustained by the labor of many people, ranging from doctors to nursing home administrators, nursing aides to psychiatrists, physical therapists to researchers, scientists to marketing directors.” Moreover, he states that the MIC is perpetuated by pharmaceutical companies, medical ad agencies, laboratories and all health facilities. Simultaneously, Clare acknowledges that cure, and thus the medical industrial complex, has helped many individuals to cope with chronic diseases or illnesses that have caused them pain. Throughout his novel, Brilliant Imperfection: Battling with Cure, Clare suggests that we, as a society, must work to re-imagine a world with a more nuanced and critical view of cure and the MIC.

Another alternative approach to the MIC is mindfulness, which emphasizes how the resources and tools for healing exist within the self and not within the solutions offered by the medical-industrial complex. Another distinct approach from the medical-industrial complex is alternative health, which incorporates elements of traditional medicine and focuses on addressing underlying factors of disease rather than merely treating symptoms. Alternative health, as a new social movement, provides a space for individuals and communities with diverse lived experiences to actively participate in the healthcare system while emphasizing their humanity in the healing process. Scholars Jonathan Metzl and Helena Hansen advocate for a new approach to medical education in the United States, termed structural competency, which entails clinicians' ability to comprehend and address social determinants of health during patient interactions.